Concepedia
Statistics
Publications
12
Citations
606
H-Index
11
Active since
2009
Affiliations
Spirogen (United Kingdom)(Current)
Amplimmune (United States)
University College London
University of Cambridge
Altimmune (United States)
Philip W. Howard is an author at Spirogen (United Kingdom) specializing in antibody-drug conjugates, pharmacy, and pharmacology.
Publications per year
2009–2020
A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology
Scott C. Jeffrey, Patrick Burke, Robert P. Lyon et al. · Bioconjugate Chemistry · 2013 · 246 citations
Pharmacy, Oncology, Pharmacology +17
Discovery of Peptidomimetic Antibody–Drug Conjugate Linkers with Enhanced Protease Specificity
BinQing Wei, Janet Gunzner-Toste, Hui Yao et al. · Journal of Medicinal Chemistry · 2017 · 106 citations
Pharmacy, Medicinal Chemistry, Oncology +17
Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus
Kate M. Moore, Ami V. Desai, Beatriz de Luxán‐Delgado et al. · Theranostics · 2020 · 49 citations · Full text
Medicine, Oncology, Pharmacology +16
Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine-Conjugated Antibody–Drug Conjugate Targeting 5T4
Jay Harper, Christopher Lloyd, Nazzareno Dimasi et al. · Molecular Cancer Therapeutics · 2017 · 47 citations · Full text
Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer
Song Cho, Francesca Zammarchi, David G. Williams et al. · Molecular Cancer Therapeutics · 2018 · 47 citations
Medicine, Oncology, Pharmacology +17
1–5 of 12